Tissue device study for breast reconstruction after mastectomy
Part of Cancer, Women’s health & pregnancy clinical trials.
This first-time-in-humans study tests a tissue-engineering chamber called MATTISSE® to help the healing of breast reconstruction using specific tissue flaps after mastectomy for cancer. If you qualify, you would be assessed for safety and how well the reconstructed tissue heals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You need breast reconstruction using your own tissue (not only implants), after a mastectomy for early-stage cancer
- Your surgery plan uses a specific flap type (LICAP or, if needed, LTAP), or you are switching from an implant plan to an autologous (own-tissue) plan
- Your cancer does not require radiation after surgery in the breast area or where the tissue is taken from
- You must be healthy enough for surgery and not have major conditions that could slow healing
- You can give consent, answer questionnaires, and you’re covered by a social security plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special supportive material called acellular dermal matrix in women having two-stage breast reconstruction after mastectomy. The goal is to learn how well it works when the implant is placed directly under the skin, over the chest muscle.
This trial studies breast reconstruction using implants after mastectomy (breast removal surgery). It aims to understand how different types of implants work and how patients recover.
This study tests a new supportive mesh called ARTIA for women having breast reconstruction immediately after a mastectomy. The mesh is placed under the skin to help hold a breast implant in position during a two-stage reconstruction process.
This trial tests a new mesh-like device called Melodi Matrix to support breast reconstruction after mastectomy. It may help women who are planning immediate two-stage implant reconstruction after removing one or both breasts.
This study tests a special mesh called OviTex PRS used during immediate breast reconstruction after mastectomy. The goal is to see if it is safe and effective for supporting the new breast implant.
This study looks at how a special mesh called TIGR® Matrix affects quality of life, safety, and effectiveness after breast reconstruction surgery. It is for women who need or choose to have their breasts removed and reconstructed.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.